Skip to main content
    Q

    Qiagen NV (QGEN)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE

    $49.80
    -0.09 (-0.18%)

    Market Cap: $10.30B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Qiagen NV (QGEN) Financials: Revenue, Profit and Cash Flow

    Updated Nov 4, 2026. Financial statements from company filings, amounts in US dollars.

    Qiagen NV reported revenue of $2.09B for the fiscal year ended Dec 31, 2025, up 5.7% from the year before. That year, net income was $424.88M with a net margin of 20.3%, operating cash flow was $654.33M and free cash flow was $453.28M. The quarter ended Sep 30, 2026 had revenue of $547.87M and net income of $105.66M.

    Revenue and Margins

    The operating margin was 24.9% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $1.34B, a compound annual rate of 5.1%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$2.09B+5.7%61.8%24.9%20.3%
    Dec 2024$1.98B+0.7%48.9%4.9%4.2%
    Dec 2023$1.97B-8.2%62.8%20.9%17.4%
    Dec 2022$2.14B-4.9%64.7%24.8%19.8%
    Dec 2021$2.25B+20.4%64.4%28.0%22.8%
    Dec 2020$1.87B+22.5%65.9%20.7%19.2%
    Dec 2019$1.53B+1.6%65.9%-1.7%-2.7%
    Dec 2018$1.50B+5.9%66.6%17.8%12.7%
    Dec 2017$1.42B+5.9%65.1%10.8%2.8%
    Dec 2016$1.34BN/A63.1%7.4%6.0%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 408.3% from the year before. In the quarter ended Sep 2026, net income fell 18.7% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$2.09B$1.98B$1.97B$2.14B$2.25B$1.87B$1.53B$1.50B$1.42B$1.34B
    Cost of revenue$798.50M$1.01B$731.62M$756.96M$800.84M$637.63M$521.16M$500.89M$494.98M$493.34M
    Gross profit$1.29B$967.35M$1.23B$1.38B$1.45B$1.23B$1.01B$1.00B$922.56M$844.65M
    Research and development$187.52M$193.49M$198.51M$189.86M$189.96M$149.07M$157.45M$161.85M$154.08M$176.13M
    Operating income$520.31M$97.71M$409.94M$531.46M$630.08M$386.43M-$26.14M$266.58M$153.42M$98.83M
    Net income$424.88M$83.59M$341.30M$423.21M$512.60M$359.19M-$41.45M$190.38M$40.39M$80.40M
    EBITDA$717.27M$368.26M$688.55M$779.36M$895.24M$715.80M$227.87M$499.47M$380.51M$308.99M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$547.87M$535.04M$492.32M$540.42M$532.58M$533.54M$483.46M$521.20M$501.87M$496.35M$458.80M$509.16M
    Gross profit$354.00M$340.39M$309.60M$317.27M$331.26M$334.29M$308.68M$333.29M$308.31M$34.76M$290.99M$316.10M
    Operating income$151.64M$132.40M$116.63M$153.90M$129.16M$121.90M$115.35M$119.10M$112.10M-$228.44M$94.95M$110.61M
    Net income$105.66M$103.40M$68.04M$107.83M$130.04M$96.25M$90.76M$88.32M$98.06M-$183.46M$80.67M$97.66M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, long-term debt of $1.65B exceeded cash and equivalents by $815.42M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$6.30B$5.69B$6.12B$6.29B$6.15B$5.87B$5.24B$5.75B$5.04B$4.31B
    Current assets$2.00B$1.96B$2.15B$2.39B$2.11B$1.62B$1.57B$2.16B$1.65B$1.04B
    Cash and equivalents$839.00M$663.55M$668.08M$730.67M$880.52M$597.98M$623.65M$1.18B$657.71M$439.18M
    Total liabilities$2.52B$2.12B$2.31B$2.82B$3.05B$3.07B$2.70B$3.11B$2.50B$1.70B
    Short-term debtN/A$77.82M$610.24M$411.77M$869.67M$65.99M$303.98M$503.18M$1.36M$999.00K
    Long-term debt$1.65B$1.34B$921.82M$1.47B$1.09B$1.88B$1.42B$1.67B$1.76B$1.07B
    Shareholder equity$3.78B$3.57B$3.81B$3.47B$3.10B$2.80B$2.54B$2.63B$2.54B$2.61B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$5.94B$5.89B$5.78B$6.30B$6.55B$5.82B$5.55B$5.69B$6.27B$5.58B$5.81B$6.12B
    Total liabilities$2.47B$2.53B$2.45B$2.52B$2.90B$2.32B$2.14B$2.12B$2.74B$2.18B$2.21B$2.31B
    Cash and equivalents$805.13M$768.50M$646.29M$839.00M$1.36B$733.82M$638.76M$663.55M$972.99M$533.64M$513.67M$668.08M
    Shareholder equity$3.47B$3.36B$3.33B$3.78B$3.65B$3.51B$3.41B$3.57B$3.53B$3.41B$3.60B$3.81B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 69.3% of operating cash flow. Dividends came to 12.0% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$654.33M$673.55M$459.45M$715.26M$639.00M$492.27M$330.84M$359.50M$286.78M$341.60M
    Capital expenditures$201.05M$167.17M$162.80M$149.34M$206.53M$304.24M$274.88M$150.76M$124.41M$93.92M
    Free cash flow$453.28M$506.38M$296.65M$565.93M$432.47M$188.03M$55.96M$208.73M$162.37M$247.68M
    Dividends paid$54.24M$0$0$25.36MN/A$622.20MN/A$567.28M$769.66MN/A
    Investing cash flow-$305.28M-$249.23M-$87.66M-$726.76M-$202.43M-$443.28M-$222.28M-$211.36M-$464.26M-$179.06M
    Financing cash flow-$178.98M-$422.90M-$433.83M-$125.80M-$150.37M-$74.32M-$639.08M$360.41M$387.19M-$10.60M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$145.63M$200.69M$100.63M$188.13M$165.02M$161.44M$139.74M$191.51M$182.35M$166.62M$133.08M$151.37M
    Capital expenditures$40.03M$42.93M$46.88M$70.91M$46.05M$40.84M$43.90M$49.66M$44.32M$38.91M$38.36M$52.22M
    Free cash flow$105.59M$157.76M$53.75M$117.22M$118.97M$120.60M$95.84M$141.85M$138.03M$127.71M$94.72M$99.15M
    Last 12 quarters

    Frequently Asked Questions About QGEN

    What is Qiagen NV's annual revenue?

    Qiagen NV reported revenue of $2.09B for the fiscal year ended Dec 31, 2025.

    How fast is Qiagen NV's revenue growing?

    Revenue was up 5.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -0.8%.

    Is Qiagen NV profitable?

    Yes. Qiagen NV reported net income of $424.88M for the fiscal year ended Dec 31, 2025, with a net margin of 20.3%.

    How much free cash flow does QGEN generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $654.33M minus capital expenditures of $201.05M produced free cash flow of $453.28M.

    How much debt does Qiagen NV have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $1.65B and cash and equivalents of $839.00M.